The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Miller Richard A Md since year 2005.
The trader's CIK number is 1031847.
At the time of this reporting, Miller Richard A Md is the President and CEO of Corvus Pharmaceuticals, Inc. .
(stock ticker symbol CRVS).
See this page for all insider trading activities at Corvus Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-12-06||CRVS||Corvus Pharmaceuticals, Inc.||Buy||5,000||5.99||29,935|
|2018-12-04||CRVS||Corvus Pharmaceuticals, Inc.||Buy||1,502||5.95||8,936|
|2018-03-12||CRVS||Corvus Pharmaceuticals, Inc.||Buy||100,000||8.50||850,000|
|2017-11-20||CRVS||Corvus Pharmaceuticals, Inc.||Buy||10,000||10.79||107,850|
|2017-06-13||CRVS||Corvus Pharmaceuticals, Inc.||Buy||5,000||9.95||49,725|
|2017-06-12||CRVS||Corvus Pharmaceuticals, Inc.||Buy||11,216||9.82||110,185|
|2017-06-09||CRVS||Corvus Pharmaceuticals, Inc.||Buy||8,784||9.92||87,137|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Miller Richard A Md (President and CEO of Corvus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.